The B4D team is a highly experienced and innovative management team with expertise in identifying attractive drug candidates, target indications, designing and managing outsourced clinical development programs and negotiating licensing deals. Our experience is unique in that it spans discovery through preclinical and clinical all the way through to regulatory approval and marketing. We have expertise across a number of therapeutic areas with particular strength in inflammation, cancer and women’s health, working with proteins, peptides and small molecules.
| Website | https://biocatalyst4development.com |
| Revenue | $3 million |
| Employees | 3 (1 on RocketReach) |
| Industry | Biotechnology Research, Drug Stores & Pharmacies, Retail |
| Keywords | Drug Development, Drug Discovery, Clinical Trials, Clinical Research, Biotechnology, Drug Candidates, Biopharmaceutical, Clinical Management, Contract Research Organization, Life Sciences, Pharmaceutical, Pharmaceutical Development, Preclinical Development, Licensing Deals, Regulatory Affairs, Process Development, Management Consulting, Drug Commercialization |
| Competitors | Codexis, Inc., Novozymes, DSM, Amano Enzyme Europe, Geno, Green Biologics Ltd., BASF, AstraZeneca, Evonik, Zymergen, Inc. +33 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Biocatalyst4Development Inc. employee's phone or email?
Biocatalyst4Development Inc. Questions
The Biocatalyst4Development Inc. annual revenue was $3 million in 2026.
Patricia Griffin is the Managing Director of Biocatalyst4Development Inc..
1 people are employed at Biocatalyst4Development Inc..
Biocatalyst4Development Inc. is based in Toronto, Ontario.
The NAICS codes for Biocatalyst4Development Inc. are [32541, 325, 3254, 32].
The SIC codes for Biocatalyst4Development Inc. are [28, 283].
Top Biocatalyst4Development Inc. Employees
Related Companies
